Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Galectin Therapeutics Inc. (GALT) had Pre-Tax Income of $-47.05M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-47.20M |
|
-- |
|
-- |
|
$42.43M |
|
$-42.43M |
|
$-4.61M |
|
|
Pre-Tax Income |
$-47.05M |
$-47.05M |
|
$-47.05M |
|
$-47.05M |
|
$-47.05M |
|
$-47.05M |
|
$-42.43M |
|
$-42.40M |
|
62.31M |
|
62.31M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$17.25M |
|
-- |
|
$0.24M |
|
$17.50M |
|
$35.41M |
|
$85.11M |
|
$85.16M |
|
$120.56M |
|
$-105.29M |
|
$-103.07M |
|
$-103.07M |
|
63.16M |
|
| Cash Flow Statement Financials | |
$-41.77M |
|
-- |
|
$31.23M |
|
$25.66M |
|
$15.12M |
|
$-10.54M |
|
$2.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.49 |
|
-- |
|
-- |
|
-4.74 |
|
-1.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-41.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
44.68% |
|
45.65% |
|
-268.92% |
|
261.94% |
|
$-1.63 |
|
$-0.67 |
|
$-0.67 |
|